Tristel ( (GB:TSTL) ) has shared an announcement.
Tristel plc announced that its Chief Financial Officer, Liz Dixon, purchased 5,000 ordinary shares of the company at a price of 291.99 pence per share, increasing her beneficial interest to 155,000 shares, which represents 0.32% of the company’s total issued share capital. This transaction reflects confidence in the company’s operations and could positively impact stakeholder perception, reinforcing Tristel’s strong positioning in the infection prevention industry.
More about Tristel
Tristel plc is a global infection prevention company specializing in the manufacture and supply of products utilizing its proprietary chlorine dioxide chemistry. The company is a market leader in manual decontamination of medical devices and provides sustainable sporicidal surface disinfection products. Tristel operates globally with its head office and manufacturing facility located in Snailwell, near Cambridge, and employs approximately 250 people across 14 subsidiaries, selling into 40 countries. It has been listed on the London Stock Exchange’s AIM market since 2005.
YTD Price Performance: -31.82%
Average Trading Volume: 78,895
Technical Sentiment Signal: Buy
Current Market Cap: £140.7M
For a thorough assessment of TSTL stock, go to TipRanks’ Stock Analysis page.